GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy.
about
Complex role of autophagy in regulation of hepatic lipid and lipoprotein metabolismInflammation Meets Metabolic Disease: Gut Feeling Mediated by GLP-1Pharmacological Modulators of Endoplasmic Reticulum Stress in Metabolic DiseasesIncretin based therapies: a novel treatment approach for non-alcoholic fatty liver diseaseInterplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathyNon-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?Regulation of lipid stores and metabolism by lipophagyLiraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trialSafety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program.Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease.Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas.G protein-coupled receptors and the regulation of autophagy.Modern approach to the clinical management of non-alcoholic fatty liver diseaseTranslational approaches: from fatty liver to non-alcoholic steatohepatitis.Potential roles of glucagon-like peptide-1-based therapies in treating non-alcoholic fatty liver disease.Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits.Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammationMitigation of autophagy ameliorates hepatocellular damage following ischemia-reperfusion injury in murine steatotic liver.Interleukin-22 Alleviated Palmitate-Induced Endoplasmic Reticulum Stress in INS-1 Cells through Activation of Autophagy.Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet.Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis.Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease.Cardiovascular biology of the incretin system.Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.Sitagliptin decreases ventricular arrhythmias by attenuated glucose-dependent insulinotropic polypeptide (GIP)-dependent resistin signalling in infarcted ratsEffect of Exendin-4 on Autophagy Clearance in Beta Cell of Rats with Tacrolimus-induced Diabetes Mellitus.Extrapancreatic effects of incretin hormones: evidence for weight-independent changes in morphological aspects and oxidative status in insulin-sensitive organs of the obese nondiabetic Zucker rat (ZFR).Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment.The role of gastrointestinal hormones in hepatic lipid metabolism.Pathophysiology of NASH: perspectives for a targeted treatment.Red carpeting the newer antidiabetics.Nonalcoholic fatty liver disease: current issues and novel treatment approaches.Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.The unfolded protein response in fatty liver disease.Autophagy--a key player in cellular and body metabolism.Insulin sensitizers for the treatment of non-alcoholic fatty liver diseaseRole of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue.GLP-1 receptor agonists: effects on the progression of non-alcoholic fatty liver disease.Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease.XBP1s Is an Anti-lipogenic Protein.
P2860
Q26747101-E8F7A5F5-E2FD-4333-9F62-BBB031270EFBQ26752511-28922B79-734F-4809-918B-36E461586E68Q26769765-F8F8E299-553D-4760-AFBE-3C90661B997CQ26827183-BF8120AC-0E8B-4DA8-A29C-11C2D915C9ADQ27001165-4A8EC7DD-9F55-4FD5-B066-2F1BE3789104Q27006992-AD0CD936-624D-4D41-A22C-8FF0A4B4D680Q27009151-AF34D0C0-4E1E-43E2-BC34-E081DDCA1331Q28661700-B3296CD0-30B7-409B-BE92-FCE2821F2C38Q30577903-50BA75DA-86C5-4E80-B1C5-638821A16484Q31149434-1BEFFBBF-AE5E-4B35-AFD2-A8F185EB80D8Q33603384-B6556E6F-29C0-48BD-93DC-17CC6DB455E2Q33847091-CFD89656-A241-4DE1-8138-B813AB48CC0BQ33886923-4E743A8E-ADAB-4E5B-82D9-83584B6BBB1DQ33958697-F705D09F-932D-453D-87F1-107984200144Q33970970-FFE2355F-687F-4726-A844-5BBA96A89569Q34379379-8E06386F-B525-40B2-8F9C-21D6D74109CAQ34405101-06B8E39A-5087-491A-91FD-4CA75AD521DDQ34627493-B96D33E8-5397-40F6-B037-DD460C0F6EFEQ35897730-C1FCAFA5-9181-40B0-A3BF-E8AE1A47D182Q35925169-0FEF4FDD-27C3-4DAB-BD97-16305B6F35FBQ36465496-1748C56B-2A0C-4158-9029-059574D9FFD6Q36470320-4AFBE68D-7639-4C85-B3EA-489DAB072DB3Q36484283-D608C5AD-9DC1-4E8E-BBF8-90CC4424F9D3Q36505119-C7E53130-E7DE-448B-BCF4-93AFC1641310Q36691245-AD52DE90-9625-42D6-9AF3-C5F7D223D2A4Q37111103-DB9D2312-A567-43AB-A610-75868234BC04Q37176743-16700432-A027-43F8-A0AB-674640494A30Q37375539-C13AF527-8C71-4C20-832C-30DA0307195BQ37640700-57A87183-D119-4D58-BA23-F8C35CA210C6Q37699476-BD52FC1D-AE7C-452F-BCB2-5AF010F7D871Q38013105-9843A8CC-7593-4B68-88EA-04B9527BB84EQ38074898-F46A220D-AE08-440C-857B-6B6CFA300843Q38121574-62AA8CA9-1FAB-4851-A789-5390C38B78F1Q38162132-9389EB13-0F70-42FB-AF02-28074399D536Q38198952-EBE21E38-7495-4F4E-9DC1-5B7936E4F528Q38209666-E7AA9813-95CE-477E-BAAD-994230E6ED9AQ38223370-F18ACBBC-BA17-44CD-98A8-E6BDFB36A7AAQ38234416-A8F30A4C-379C-4CFF-9DF9-0FD28EF71CEEQ38261236-5D1B2447-9FDC-446F-8DE0-658A7D7FD9BCQ38291938-60D95421-FA90-4E51-AAA6-2606A69400FF
P2860
GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
GLP-1 analogs reduce hepatocyt ...... and promoting macroautophagy.
@ast
GLP-1 analogs reduce hepatocyt ...... and promoting macroautophagy.
@en
GLP-1 analogs reduce hepatocyt ...... and promoting macroautophagy.
@nl
type
label
GLP-1 analogs reduce hepatocyt ...... and promoting macroautophagy.
@ast
GLP-1 analogs reduce hepatocyt ...... and promoting macroautophagy.
@en
GLP-1 analogs reduce hepatocyt ...... and promoting macroautophagy.
@nl
prefLabel
GLP-1 analogs reduce hepatocyt ...... and promoting macroautophagy.
@ast
GLP-1 analogs reduce hepatocyt ...... and promoting macroautophagy.
@en
GLP-1 analogs reduce hepatocyt ...... and promoting macroautophagy.
@nl
P2093
P2860
P1433
P1476
GLP-1 analogs reduce hepatocyt ...... and promoting macroautophagy.
@en
P2093
Frank A Anania
Jamie E Mells
Neeraj K Saxena
Shvetank Sharma
P2860
P304
P356
10.1371/JOURNAL.PONE.0025269
P407
P577
2011-09-21T00:00:00Z